The health care sector closed the day up 1.9%. Transcept Pharmaceuticals Inc ( TSPT), Mela Sciences Inc ( MELA), World Heart Corporation ( WHRT), and Tranzyme Inc ( TZYM) were all winners today within the health care sector with Bristol-Myers Squibb Company ( BMY) being today's featured health care winner. Bristol-Myers Squibb Company rose 35 cents (1.1%) to $31.84 on heavy volume. Throughout the day, 23.8 million shares of Bristol-Myers Squibb Company exchanged hands as compared to its average daily volume of 13.9 million shares. Bristol-Myers Squibb Company, a global biopharmaceutical company, discovers, develops, and delivers innovative medicines that help patients prevail over serious diseases. Bristol-Myers Squibb Company has a market cap of $53.5 billion and is part of the drugs industry. The company has a P/E ratio of 16.3, equal to the average drugs industry P/E ratio and below the S&P 500 P/E ratio of 17.7. Shares are up 18.5% year to date as of the close of trading on Monday. TheStreet Ratings rates Bristol-Myers Squibb as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, reasonable valuation levels, good cash flow from operations and increase in stock price during the past year. We feel these strengths outweigh the fact that the company has had sub par growth in net income.
- You can view the full Bristol-Myers Squibb Ratings Report.
- Use our health care section to find sector-relevant news.
- Or find some new ideas from our top rated stocks lists.
- Find other investment ideas from our top rated ETFs lists.